The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells
14 Feb 2022 10:15 AM GMT
The study is the first to show evACE2 proteins are capable of fighting the new SARS-CoV-2 variants
24 Jan 2022 6:54 AM GMT